Get started
Author

Laura G. Draijer

Observed names: Draijer L, Draijer, Laura, Draijer, Laura G, Draijer, Laura G., L.G. Draijer, Laura Draijer
Observed institutions: Amsterdam UMC Location University of Amsterdam, Emma Kinderziekenhuis, Amsterdam University Medical Centers, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam Reproduction Development, Dijklander Ziekenhuis, University of Amsterdam
ORCID: 0000-0002-1840-1692
Observed ORCID: 0000-0002-1840-1692
OpenAlex ID: A5021068183
Pediatric NAFLD: an overview and recent developments in diagnostics and treatment
2019 · Laura Draijer, Marc Benninga, et al. · Expert Review of Gastroenterology & Hepatology · 102
PDF
Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis
2020 · Mark R. Deneau, Cara Mack, et al. · Hepatology · 97
Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease
2019 · Laura G. Draijer, Sana Feddouli, et al. · European Journal of Pediatrics · 71
PDF
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children
2020 · Mark R. Deneau, Cara Mack, et al. · Hepatology · 47
PDF
Diagnostic accuracy of fibrosis tests in children with non‐alcoholic fatty liver disease: A systematic review
2021 · Laura G. Draijer, Janneke P. M. van Oosterhout, et al. · Liver International · 42
PDF
Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity
2020 · Jurgen H. Runge, Jet van Giessen, et al. · European Radiology · 39
PDF
Lipidomics in Nonalcoholic Fatty Liver Disease
2020 · Laura G. Draijer, Denise Froon‐Torenstra, et al. · Journal of Pediatric Gastroenterology and Nutrition · 38
Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease
2023 · Laura Kalveram, Ulrich Baumann, et al. · Journal of Pediatric Gastroenterology and Nutrition · 36
PDF
A natural history study of paediatric non-alcoholic fatty liver disease over 10 years
2023 · Laura Draijer, Maaike Voorhoeve, et al. · JHEP Reports · 35
PDF
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17‐beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms
2022 · Christian A. Hudert, Leon A. Adams, et al. · Hepatology Communications · 35
Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis
2020 · Wael El-Matary, Stephen L. Guthery, et al. · Clinical Gastroenterology and Hepatology · 29
Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study
2021 · Mercedes Martinez, Emily R. Perito, et al. · Hepatology · 23
Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis
2020 · Trevor J. Laborda, Amanda Ricciuto, et al. · Journal of Pediatric Gastroenterology and Nutrition · 18
Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults
2022 · Jake P. Mann, Benjamin Jenkins, et al. · Journal of Pediatric Gastroenterology and Nutrition · 15
ALT Is an Effective Screening Tool for Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease in Children With Obesity and Overweight
2025 · Anne-Sophie R. Stroes, Laura Draijer, et al. · Clinical Gastroenterology and Hepatology · 13
Evaluation of the feasibility of screening for paediatric non‐alcoholic fatty liver disease
2022 · Laura Draijer, Maaike Voorhoeve, et al. · Acta Paediatrica · 12
PDF
The prevalence of liver fibrosis according to non-invasive tools in a pediatric home parenteral nutrition cohort
2020 · Sjoerd C.J. Nagelkerke, Laura G. Draijer, et al. · Clinical Nutrition · 8
Variants in MARC1 and HSD17B13 reduce severity of NAFLD in children, perturb phospholipid metabolism, and suppress fibrotic pathways
2020 · Christian A. Hudert, Anna Alisi, et al. · medRxiv · 7
PDF
Survey on screening for paediatric non‐alcoholic fatty liver disease in clinical practice in Dutch hospitals
2020 · Laura G. Draijer, Sabine Haggenburg, et al. · Acta Paediatrica · 7
PDF
Assessing the Validity of Adult‐derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children
2019 · Mark R. Deneau, Pamela L. Valentino, et al. · Journal of Pediatric Gastroenterology and Nutrition · 5
PDF
Screening for lysosomal acid lipase deficiency: A retrospective data mining study and evaluation of screening criteria
2018 · Laura G. Draijer, Annet M. Bosch, et al. · Atherosclerosis · 2
Children’s experience of screening and evaluation for MASLD in overweight and obesity
2025 · Anne-Sophie R. Stroes, Laura Draijer, et al. · Obesity Research & Clinical Practice · 1
WED-371 ALT is an effective screening tool for advanced MASLD in children with obesity and overweight
2025 · Anne-Sophie Stroes, Laura Draijer, et al. · Journal of Hepatology · 1
Costs of two-step MASLD screening using ALT and elastography in children with overweight and obesity
2026 · Anne-Sophie R. Stroes, Eva Muntjewerff, et al. · Obesity Research & Clinical Practice
PDF
Hepatic Steatosis and Cardiovascular Risk in Obesity: A 10‐Year Follow‐Up Study From Childhood Into Young Adulthood
2026 · Anne‐Sophie R. Stroes, D. Meeike Kusters, et al. · Pediatric Obesity
PDF
Works count: 36
Citation count: 683
H-index: 14
I10-index: 16
Year
Topic
Type